Published in Int J Cardiol on October 10, 2005
Muscle oxidative capacity during IL-6-dependent cancer cachexia. Am J Physiol Regul Integr Comp Physiol (2010) 1.19
PGC1α-mediated mitofusin-2 deficiency in female rats and humans with pulmonary arterial hypertension. Am J Respir Crit Care Med (2013) 1.06
IL-6 regulation on skeletal muscle mitochondrial remodeling during cancer cachexia in the ApcMin/+ mouse. Skelet Muscle (2012) 1.02
The association of growth hormone parameters with skeletal muscle phosphocreatine recovery in adult men. J Clin Endocrinol Metab (2010) 0.87
Caloric restriction induces energy-sparing alterations in skeletal muscle contraction, fiber composition and local thyroid hormone metabolism that persist during catch-up fat upon refeeding. Front Physiol (2015) 0.81
The effects of tesamorelin on phosphocreatine recovery in obese subjects with reduced GH. J Clin Endocrinol Metab (2013) 0.79
Relationship between serum IGF-1 and skeletal muscle IGF-1 mRNA expression to phosphocreatine recovery after exercise in obese men with reduced GH. J Clin Endocrinol Metab (2014) 0.79
Adiponectin resistance in skeletal muscle: pathophysiological implications in chronic heart failure. J Cachexia Sarcopenia Muscle (2015) 0.78
Aerobic Exercise and Pharmacological Therapies for Skeletal Myopathy in Heart Failure: Similarities and Differences. Oxid Med Cell Longev (2016) 0.78
The emerging role of skeletal muscle oxidative metabolism as a biological target and cellular regulator of cancer-induced muscle wasting. Semin Cell Dev Biol (2015) 0.77
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J (2010) 16.39
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace (2010) 6.31
Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant (2005) 5.87
A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur Heart J (2007) 2.76
Human amniotic fluid-derived stem cells are rejected after transplantation in the myocardium of normal, ischemic, immuno-suppressed or immuno-deficient rat. J Mol Cell Cardiol (2006) 1.99
Pathology of pulmonary antibody-mediated rejection: 2012 update from the Pathology Council of the ISHLT. J Heart Lung Transplant (2013) 1.71
Acute biopsy-proven lymphocytic myocarditis mimicking Takotsubo cardiomyopathy. Eur J Heart Fail (2009) 1.44
Widespread increase in myeloid calcifying cells contributes to ectopic vascular calcification in type 2 diabetes. Circ Res (2011) 1.41
Report from a consensus conference on antibody-mediated rejection in heart transplantation. J Heart Lung Transplant (2011) 1.40
Intracardiac echocardiography: gross anatomy and magnetic resonance correlations and validations. Int J Cardiovasc Imaging (2005) 1.38
2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology. Cardiovasc Pathol (2011) 1.24
The ISHLT working formulation for pathologic diagnosis of antibody-mediated rejection in heart transplantation: evolution and current status (2005-2011). J Heart Lung Transplant (2011) 1.20
The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation. J Heart Lung Transplant (2013) 1.16
Surgical vs medical treatment for isolated internal carotid artery elongation with coiling or kinking in symptomatic patients: a prospective randomized clinical study. J Vasc Surg (2005) 1.15
Overexpression of tumor necrosis factor (TNF)alpha and TNFalpha receptor I in human viral myocarditis: clinicopathologic correlations. Mod Pathol (2004) 1.13
Alpha-actin isoform distribution in normal and failing human heart: a morphological, morphometric, and biochemical study. J Pathol (2003) 1.03
Exercise intolerance in chronic heart failure: mechanisms and therapies. Part I. Eur J Cardiovasc Prev Rehabil (2010) 1.03
Skeletal muscle myofibrillar protein oxidation in heart failure and the protective effect of Carvedilol. J Mol Cell Cardiol (2005) 1.00
Stem cell compartmentalization in diabetes and high cardiovascular risk reveals the role of DPP-4 in diabetic stem cell mobilopathy. Basic Res Cardiol (2012) 1.00
L-Carnitine: a potential treatment for blocking apoptosis and preventing skeletal muscle myopathy in heart failure. Am J Physiol Cell Physiol (2002) 0.98
Molecular diagnosis of myocarditis and dilated cardiomyopathy in children: clinicopathologic features and prognostic implications. Diagn Mol Pathol (2002) 0.98
A transient antioxidant stress response accompanies the onset of disuse atrophy in human skeletal muscle. J Appl Physiol (1985) (2009) 0.97
Exercise intolerance in chronic heart failure: mechanisms and therapies. Part II. Eur J Cardiovasc Prev Rehabil (2010) 0.97
Leaflet escape in a new bileaflet mechanical valve: TRI technologies. Circulation (2003) 0.96
Immune and nonimmune predictors of cardiac allograft vasculopathy onset and severity: multivariate risk factor analysis and role of immunosuppression. Am J Transplant (2004) 0.95
Amniotic mesenchymal cells autotransplanted in a porcine model of cardiac ischemia do not differentiate to cardiogenic phenotypes. Eur J Cardiothorac Surg (2005) 0.95
Extracellular matrix graft for vascular reconstructive surgery: evidence of autologous regeneration of the neoaorta in a murine model. Eur J Cardiothorac Surg (2012) 0.93
Sphingosine 1-phosphate protects mouse extensor digitorum longus skeletal muscle during fatigue. Am J Physiol Cell Physiol (2005) 0.93
Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients. Arch Dermatol (2004) 0.92
Beneficial effects of GH/IGF-1 on skeletal muscle atrophy and function in experimental heart failure. Am J Physiol Cell Physiol (2003) 0.92
Pathological changes and myocardial remodelling related to the mode of shunting following surgical palliation for hypoplastic left heart syndrome. Cardiol Young (2008) 0.92
Successful treatment of enterovirus-induced myocarditis with interferon-alpha. J Heart Lung Transplant (2003) 0.91
Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy. Eur Heart J (2010) 0.89
Impact of the phosphatidylinositide 3-kinase signaling pathway on the cardioprotection induced by intermittent hypoxia. PLoS One (2013) 0.89
Can C4d immunostaining on endomyocardial biopsies be considered a prognostic biomarker in heart transplant recipients? Transplantation (2010) 0.88
Stem-cell therapy in an experimental model of pulmonary hypertension and right heart failure: role of paracrine and neurohormonal milieu in the remodeling process. J Heart Lung Transplant (2011) 0.87
Trophic action of sphingosine 1-phosphate in denervated rat soleus muscle. Am J Physiol Cell Physiol (2007) 0.87
Sparing of muscle mass and function by passive loading in an experimental intensive care unit model. J Physiol (2012) 0.87
Skeletal muscle myofibrillar protein oxidation and exercise capacity in heart failure. Basic Res Cardiol (2007) 0.87
Unusual high exposure to ultraviolet-C radiation. Photochem Photobiol (2007) 0.86
Coronary flow velocity pattern and coronary flow reserve by contrast-enhanced transthoracic echocardiography predict long-term outcome in heart transplantation. Circulation (2006) 0.86
Skeletal muscle proteins oxidation in chronic right heart failure in rats: can different beta-blockers prevent it to the same degree? Int J Cardiol (2009) 0.86
Bone-marrow-derived CXCR4-positive tissue-committed stem cell recruitment in human right ventricular remodeling. Hum Pathol (2010) 0.85
Classification and histological, immunohistochemical, and molecular diagnosis of inflammatory myocardial disease. Heart Fail Rev (2013) 0.85
Recent developments on coronary microvasculopathy after heart transplantation: a new target in the therapy of cardiac allograft vasculopathy. Curr Vasc Pharmacol (2012) 0.84
Intravascular macrophages in cardiac allograft biopsies for diagnosis of early and late antibody-mediated rejection. J Heart Lung Transplant (2013) 0.83
From molecular mechanisms of cardiac development to genetic substrate of congenital heart diseases. Future Cardiol (2010) 0.83
Skeletal muscle wastage in Crohn's disease: a pathway shared with heart failure? Int J Cardiol (2007) 0.83
Endovascular treatment of in-stent restenosis after carotid artery stenting: immediate and midterm results. J Endovasc Ther (2006) 0.82
Skeletal muscle abnormalities in rats with experimentally induced heart hypertrophy and failure. Basic Res Cardiol (2003) 0.82
Twenty years of progress and beckoning frontiers in cardiovascular pathology: cardiomyopathies. Cardiovasc Pathol (2005) 0.82
Outcome after pediatric heart transplantation: two decades of a single center experience. Eur J Cardiothorac Surg (2007) 0.82
R25C mutation in the NKX2.5 gene in Italian patients affected with non-syndromic and syndromic congenital heart disease. J Cardiovasc Med (Hagerstown) (2013) 0.81
Role of morphologic parameters on endomyocardial biopsy to detect sub-clinical antibody-mediated rejection in heart transplantation. J Heart Lung Transplant (2011) 0.81
Carnitine-mediated improved response to erythropoietin involves induction of haem oxygenase-1: studies in humans and in an animal model. Nephrol Dial Transplant (2007) 0.80
Rituximab in recurrent idiopathic giant cell myocarditis after heart transplantation: a potential therapeutic approach. Transpl Int (2014) 0.80
Impaired endothelial progenitor cell recruitment may contribute to heart transplant microvasculopathy. J Heart Lung Transplant (2010) 0.80
Images in cardio-thoracic surgery: Intimo-intimal intussusception: a rare complication of Stanford type A acute aortic dissection. Eur J Cardiothorac Surg (2009) 0.79
ABO-incompatible heart transplantation: crossing the immunological barrier. J Cardiovasc Med (Hagerstown) (2008) 0.79
Three-dimensional molecular reconstruction of rat heart with mass spectrometry imaging. Anal Bioanal Chem (2012) 0.79
Effects of inactivity on human muscle glutathione synthesis by a double-tracer and single-biopsy approach. J Physiol (2010) 0.79
C2 is superior to C0 as predictor of renal toxicity and rejection risk profile in stable heart transplant recipients. Transpl Int (2005) 0.79
Pro-Apoptotic Effects of Plasma from Patients with Cardiorenal Syndrome on Human Tubular Cells. Am J Nephrol (2015) 0.78
Skeletal muscle apoptosis in experimental heart failure: the only link between inflammation and skeletal muscle wastage? Curr Opin Clin Nutr Metab Care (2006) 0.78
AECVP and SCVP 2009 recommendations for training in cardiovascular pathology. Cardiovasc Pathol (2010) 0.77
Effect of thalidomide on the skeletal muscle in experimental heart failure. Eur J Heart Fail (2002) 0.76
[Consensus document on endomyocardial biopsy of the Associazione per la Patologia Cardiovascolare Italiana]. G Ital Cardiol (Rome) (2009) 0.76
The contribution of stem cell therapy to skeletal muscle remodeling in heart failure. Int J Cardiol (2013) 0.76
Determinants of coronary flow reserve in heart transplantation: a study performed with contrast-enhanced echocardiography. J Heart Lung Transplant (2009) 0.76
Fatal outcome in Eisenmenger syndrome. Cardiovasc Pathol (2002) 0.76
Endothelin A-receptor antagonist administration immediately after experimental myocardial infarction with reperfusion does not affect scar healing in dogs. Cardiovasc Res (2002) 0.75
The peritoneum as a natural scaffold for vascular regeneration. PLoS One (2012) 0.75
Who has inflamed my heart and makes my body burn? The Othello's dilemma in heart failure. Int J Cardiol (2008) 0.75
Stem cells and cardiac hypertrophy. Cardiol Young (2005) 0.75
The bovine jugular vein conduit for right ventricular outflow tract reconstruction: a feasible alternative to homograft conduits? J Thorac Cardiovasc Surg (2004) 0.75
[Paradigm shifts in aortic pathology: clinical and therapeutic implications. Clinical imaging in chronic and acute aortic syndromes. The aorta as a cause of cardiac disease]. G Ital Cardiol (Rome) (2014) 0.75
Directional atherectomy of a calcified lesion using a new atherectomy device. Catheter Cardiovasc Interv (2002) 0.75
Age is a risk factor for maladaptive changes in rats exposed to increased pressure loading of the right ventricular myocardium. Cardiol Young (2007) 0.75
Inflammation and perturbation of the l-carnitine system in heart failure. Eur J Heart Fail (2005) 0.75
Role of alpha5beta1 integrin and MIA (melanoma inhibitory activity) in the pathogenesis of vitiligo. J Dermatol Sci (2013) 0.75
The un-natural history of an adolescent with combined congenital and acquired heart disease. J Cardiovasc Med (Hagerstown) (2015) 0.75
Pachymeningeal involvement in POEMS syndrome: MRI and histopathological study. J Neurol Neurosurg Psychiatry (2011) 0.75